Evaluation of a Recombination-Resistant Coronavirus as a Broadly Applicable, Rapidly Implementable Vaccine Platform

Communications Biology - United States
doi 10.1038/s42003-018-0175-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC